City
Epaper

Karnataka ex-CM Siddaramaiah in Bengaluru hospital with fever

By IANS | Updated: June 2, 2021 16:24 IST

Bengaluru, June 1 Congress leader and former Karnataka Chief Minister Siddaramaiah has been admitted to a private hospital ...

Open in App

Bengaluru, June 1 Congress leader and former Karnataka Chief Minister Siddaramaiah has been admitted to a private hospital in the city with high fever, the hospital said on Tuesday.

"Siddaramaiah is admitted in our hospital for evaluation of fever. He was tested for Covid, which came negative. He is stable and being investigated and treated by a team of medical experts," the Manipal Hospital said in a statement here.

Siddaramaiah, 72, was in the same hospital in August 2020 for treatment after he tested Covid positive.

"As Siddaramaiah is down with high fever since Monday night, all his scheduled programmes for the next 2 days have been cancelled," his office said in a statement.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: congressManipal Hospital
Open in App

Related Stories

NationalLokmat Parliamentary Awards 2025: Digvijay Singh Honoured With Lifetime Achievement Award

MumbaiJolt to Congress Ahead of Local Body Polls as MLC Pradnya Satav Set to Join BJP: Reports

MaharashtraBMC Elections 2026: NCP Will Be Kept Out of BJP-Sena Alliance To Split Secular Votes, Says Congress Leader Vijay Wadettiwar

MumbaiBMC Elections 2026: Cryptic 'Marathi Manoos' Posters Surface Across Mumbai Ahead of Civic Polls

NationalSanchar Saathi Will Be An Optional App? Jyotiraditya Scindia Rejects ‘Snooping’ Claims

Health Realted Stories

HealthIndia reaffirms further healthcare support to Kabul during Afghan minister's visit

Health'Be alive to ground realities': SC refuse to entertain PIL challenged bottled water standards

HealthCRPF trooper dies of suspected cardiac arrest in J&K’s Anantnag

HealthIs high-fat cheese healthy for your brain?

HealthIndian researchers develop new peptide therapy to treat eye infections